Screener
Cogent Biosciences, Inc. COGT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Series A non-voting convertible preferred stock, $0.001 par value; 1,000,000 shares authorized; 39,414 and 67,414 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 29,190 | 53,830 |
| Series B non-voting convertible preferred stock, $0.001 par value; 20,580 shares authorized; 4,516 shares issued and outstanding at March 31, 2026 and December 31, 2025 | 35,563 | 35,563 |
| Common stock, $0.001 par value; 300,000,000 shares authorized; 170,773,803 and 160,980,024 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 171 | 161 |
| Additional paid-in capital | 1,828,956 | 1,734,882 |
| Accumulated other comprehensive income (loss) | (415) | 355 |
| Accumulated deficit | (1,285,772) | (1,188,420) |
| Total stockholders’ equity | 607,693 | 636,371 |
| Total liabilities and stockholders’ equity | $903,006 | $937,607 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cogent Biosciences, Inc.'s total equity?
- Cogent Biosciences, Inc. (COGT) reported total equity of $607.69M in Q1 2026.
- How has Cogent Biosciences, Inc.'s total equity changed year-over-year?
- Cogent Biosciences, Inc.'s total equity increased by 177.5% year-over-year, from $219M to $607.69M.
- What is the long-term trend for Cogent Biosciences, Inc.'s total equity?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s total equity has grown at a 22.1% compound annual growth rate (CAGR), from $234.67M to $636.37M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Cogent Biosciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude